Brief: Syros Presents Data From Phase 1/1B Clinical Trial Of Sy-5609 In Advanced Solid Tumors At ASCO Annual Meeting
May 25 (Reuters) - Syros Pharmaceuticals Inc SYRS.O :
* SYROS PRESENTS DATA FROM PHASE 1/1B CLINICAL TRIAL OF
SY-5609 IN
ADVANCED SOLID TUMORS AT ASCO ANNUAL MEETING
* SYROS PHARMACEUTICALS INC - EXPLORING PARTNERSHIP
OPPORTUNITIES
TO ADVANCE DEVELOPMENT OF SY-5609
Source text for Eikon: ID:nBw16j7Y1a
Further company coverage: SYRS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Syros Pharmaceuticals
See all newsU.S. STOCKS ON THE MOVE-Elevance, Backblaze, Disney
Syros Pharmaceuticals hits record low on QIAGEN deal termination and leadership changes
U.S. STOCKS ON THE MOVE-Charter Communications, BioNTech, Big US banks
U.S. STOCKS ON THE MOVE-BankUnited, Natera, Adaptimmune
Syros falls after blood cancer drug fails in late-stage trial